Texas HIV/STD 2016 Pre-Conference Survey

Question Title

* 1. Have you attended a past Texas HIV/STD Conference?

Yes

No

Question Title

* 2. If yes, select the years you have attended:

2014

2012

2010

2008

2006

2004

Conference(s) prior to 2004

Question Title

* 3. Do you plan to attend the 2016 Texas HIV/STD Conference on October 4-6, 2016 in Austin?

Question Title

* 4. If not, Why not?

For each track, indicate your level of interest in learning about each of the listed topics at the 2016 conference.

Question Title

* 5. PREVENTION

	Very interested	Somewhat interested	Neutral	Not so interested	No interest
PrEP and Other Bio-Medical Interventions	PrEP and Other Bio-Medical Interventions Very interested	PrEP and Other Bio-Medical Interventions Somewhat interested	PrEP and Other Bio-Medical Interventions Neutral	PrEP and Other Bio-Medical Interventions Not so interested	PrEP and Other Bio-Medical Interventions No interest
New STD Treatment Guidelines	New STD Treatment Guidelines Very interested	New STD Treatment Guidelines Somewhat interested	New STD Treatment Guidelines Neutral	New STD Treatment Guidelines Not so interested	New STD Treatment Guidelines No interest
STD Co-Infection and HIV Risk	STD Co-Infection and HIV Risk Very interested	STD Co-Infection and HIV Risk Somewhat interested	STD Co-Infection and HIV Risk Neutral	STD Co-Infection and HIV Risk Not so interested	STD Co-Infection and HIV Risk No interest
Transgender Health	Transgender Health Very interested	Transgender Health Somewhat interested	Transgender Health Neutral	Transgender Health Not so interested	Transgender Health No interest
Using Social Media for HIV/STD Prevention	Using Social Media for HIV/STD Prevention Very interested	Using Social Media for HIV/STD Prevention Somewhat interested	Using Social Media for HIV/STD Prevention Neutral	Using Social Media for HIV/STD Prevention Not so interested	Using Social Media for HIV/STD Prevention No interest
Data to Care	Data to Care Very interested	Data to Care Somewhat interested	Data to Care Neutral	Data to Care Not so interested	Data to Care No interest
IDU and Substance Abuse	IDU and Substance Abuse Very interested	IDU and Substance Abuse Somewhat interested	IDU and Substance Abuse Neutral	IDU and Substance Abuse Not so interested	IDU and Substance Abuse No interest
Telemedicine	Telemedicine Very interested	Telemedicine Somewhat interested	Telemedicine Neutral	Telemedicine Not so interested	Telemedicine No interest
PrEP and STD Clinics	PrEP and STD Clinics Very interested	PrEP and STD Clinics Somewhat interested	PrEP and STD Clinics Neutral	PrEP and STD Clinics Not so interested	PrEP and STD Clinics No interest
Neuroscience: Sex and Drug Use	Neuroscience: Sex and Drug Use Very interested	Neuroscience: Sex and Drug Use Somewhat interested	Neuroscience: Sex and Drug Use Neutral	Neuroscience: Sex and Drug Use Not so interested	Neuroscience: Sex and Drug Use No interest
Extragential Screening	Extragential Screening Very interested	Extragential Screening Somewhat interested	Extragential Screening Neutral	Extragential Screening Not so interested	Extragential Screening No interest

Please list any other suggested topics for this track:

Question Title

* 6. CARE AND TREATMENT

	Very interested	Somewhat interested	Neutral	Not so interested	No interest
STD Treatment Guidelines: Recent and Future	STD Treatment Guidelines: Recent and Future Very interested	STD Treatment Guidelines: Recent and Future Somewhat interested	STD Treatment Guidelines: Recent and Future Neutral	STD Treatment Guidelines: Recent and Future Not so interested	STD Treatment Guidelines: Recent and Future No interest
New Field Treatment Strategies	New Field Treatment Strategies Very interested	New Field Treatment Strategies Somewhat interested	New Field Treatment Strategies Neutral	New Field Treatment Strategies Not so interested	New Field Treatment Strategies No interest
HCV/HIV Co-Infection	HCV/HIV Co-Infection Very interested	HCV/HIV Co-Infection Somewhat interested	HCV/HIV Co-Infection Neutral	HCV/HIV Co-Infection Not so interested	HCV/HIV Co-Infection No interest
Data to Care	Data to Care Very interested	Data to Care Somewhat interested	Data to Care Neutral	Data to Care Not so interested	Data to Care No interest
Perinatal Infection/Prenatal STD Care	Perinatal Infection/Prenatal STD Care Very interested	Perinatal Infection/Prenatal STD Care Somewhat interested	Perinatal Infection/Prenatal STD Care Neutral	Perinatal Infection/Prenatal STD Care Not so interested	Perinatal Infection/Prenatal STD Care No interest
Cross-cutting Issues Affecting Congenital Syphilis	Cross-cutting Issues Affecting Congenital Syphilis Very interested	Cross-cutting Issues Affecting Congenital Syphilis Somewhat interested	Cross-cutting Issues Affecting Congenital Syphilis Neutral	Cross-cutting Issues Affecting Congenital Syphilis Not so interested	Cross-cutting Issues Affecting Congenital Syphilis No interest
Future Safety Net Services	Future Safety Net Services Very interested	Future Safety Net Services Somewhat interested	Future Safety Net Services Neutral	Future Safety Net Services Not so interested	Future Safety Net Services No interest
Linkage Activities	Linkage Activities Very interested	Linkage Activities Somewhat interested	Linkage Activities Neutral	Linkage Activities Not so interested	Linkage Activities No interest
New Policies	New Policies Very interested	New Policies Somewhat interested	New Policies Neutral	New Policies Not so interested	New Policies No interest

Please list any other suggested topics for this track:

Question Title

* 7. HEALTH EQUITY

	Very interested	Somewhat interested	Neutral	Not so interested	No interest
Larger Social Determinant Issues	Larger Social Determinant Issues Very interested	Larger Social Determinant Issues Somewhat interested	Larger Social Determinant Issues Neutral	Larger Social Determinant Issues Not so interested	Larger Social Determinant Issues No interest
Partnerships in Creating Equity	Partnerships in Creating Equity Very interested	Partnerships in Creating Equity Somewhat interested	Partnerships in Creating Equity Neutral	Partnerships in Creating Equity Not so interested	Partnerships in Creating Equity No interest
Examples of Partnerships and Coalitions	Examples of Partnerships and Coalitions Very interested	Examples of Partnerships and Coalitions Somewhat interested	Examples of Partnerships and Coalitions Neutral	Examples of Partnerships and Coalitions Not so interested	Examples of Partnerships and Coalitions No interest
Involving/Building Coalitions with Government Agencies	Involving/Building Coalitions with Government Agencies Very interested	Involving/Building Coalitions with Government Agencies Somewhat interested	Involving/Building Coalitions with Government Agencies Neutral	Involving/Building Coalitions with Government Agencies Not so interested	Involving/Building Coalitions with Government Agencies No interest
Effects of Incarceration and Reentry on Communities with High Prevalence	Effects of Incarceration and Reentry on Communities with High Prevalence Very interested	Effects of Incarceration and Reentry on Communities with High Prevalence Somewhat interested	Effects of Incarceration and Reentry on Communities with High Prevalence Neutral	Effects of Incarceration and Reentry on Communities with High Prevalence Not so interested	Effects of Incarceration and Reentry on Communities with High Prevalence No interest
PTSD in Affected Populations	PTSD in Affected Populations Very interested	PTSD in Affected Populations Somewhat interested	PTSD in Affected Populations Neutral	PTSD in Affected Populations Not so interested	PTSD in Affected Populations No interest
Role of Mental Health and Access to Mental Health Providers as a Social Determinant.	Role of Mental Health and Access to Mental Health Providers as a Social Determinant. Very interested	Role of Mental Health and Access to Mental Health Providers as a Social Determinant. Somewhat interested	Role of Mental Health and Access to Mental Health Providers as a Social Determinant. Neutral	Role of Mental Health and Access to Mental Health Providers as a Social Determinant. Not so interested	Role of Mental Health and Access to Mental Health Providers as a Social Determinant. No interest

Please list any other suggested topics for this track:

Question Title

* 8. Epidemiology and Surveillance

	Very interested	Somewhat interested	Neutral	Not so interested	No interest
Case Management Successes Within the Ryan White Program	Case Management Successes Within the Ryan White Program Very interested	Case Management Successes Within the Ryan White Program Somewhat interested	Case Management Successes Within the Ryan White Program Neutral	Case Management Successes Within the Ryan White Program Not so interested	Case Management Successes Within the Ryan White Program No interest
Linkage to Care	Linkage to Care Very interested	Linkage to Care Somewhat interested	Linkage to Care Neutral	Linkage to Care Not so interested	Linkage to Care No interest
Data to Care:Using Data to Get People Into Care	Data to Care:Using Data to Get People Into Care Very interested	Data to Care:Using Data to Get People Into Care Somewhat interested	Data to Care:Using Data to Get People Into Care Neutral	Data to Care:Using Data to Get People Into Care Not so interested	Data to Care:Using Data to Get People Into Care No interest
Getting Young MSM Linked to Care and Prevention: Challenges and Solutions	Getting Young MSM Linked to Care and Prevention: Challenges and Solutions Very interested	Getting Young MSM Linked to Care and Prevention: Challenges and Solutions Somewhat interested	Getting Young MSM Linked to Care and Prevention: Challenges and Solutions Neutral	Getting Young MSM Linked to Care and Prevention: Challenges and Solutions Not so interested	Getting Young MSM Linked to Care and Prevention: Challenges and Solutions No interest
Role of Social Networking Apps	Role of Social Networking Apps Very interested	Role of Social Networking Apps Somewhat interested	Role of Social Networking Apps Neutral	Role of Social Networking Apps Not so interested	Role of Social Networking Apps No interest
Treatment Cascade and Measuring Success in Reducing HIV	Treatment Cascade and Measuring Success in Reducing HIV Very interested	Treatment Cascade and Measuring Success in Reducing HIV Somewhat interested	Treatment Cascade and Measuring Success in Reducing HIV Neutral	Treatment Cascade and Measuring Success in Reducing HIV Not so interested	Treatment Cascade and Measuring Success in Reducing HIV No interest
HIV and Aging	HIV and Aging Very interested	HIV and Aging Somewhat interested	HIV and Aging Neutral	HIV and Aging Not so interested	HIV and Aging No interest
Cluster Analysis	Cluster Analysis Very interested	Cluster Analysis Somewhat interested	Cluster Analysis Neutral	Cluster Analysis Not so interested	Cluster Analysis No interest
Analyzing HIV Clusters Using Molecular HIV Surveillance and Partner Services Data	Analyzing HIV Clusters Using Molecular HIV Surveillance and Partner Services Data Very interested	Analyzing HIV Clusters Using Molecular HIV Surveillance and Partner Services Data Somewhat interested	Analyzing HIV Clusters Using Molecular HIV Surveillance and Partner Services Data Neutral	Analyzing HIV Clusters Using Molecular HIV Surveillance and Partner Services Data Not so interested	Analyzing HIV Clusters Using Molecular HIV Surveillance and Partner Services Data No interest
Co-Infection with STD/HCV	Co-Infection with STD/HCV Very interested	Co-Infection with STD/HCV Somewhat interested	Co-Infection with STD/HCV Neutral	Co-Infection with STD/HCV Not so interested	Co-Infection with STD/HCV No interest

Please list any other suggested topics for this track:

Question Title

* 9. LEADERSHIP/ADMINISTRATION

	Very Interested	Somewhat interested	Neutral	Not so interested	No interest
How Best to Interface with Government about Public Health	How Best to Interface with Government about Public Health Very Interested	How Best to Interface with Government about Public Health Somewhat interested	How Best to Interface with Government about Public Health Neutral	How Best to Interface with Government about Public Health Not so interested	How Best to Interface with Government about Public Health No interest
Cultivating HIV Advocacy and Expertise in Texas	Cultivating HIV Advocacy and Expertise in Texas Very Interested	Cultivating HIV Advocacy and Expertise in Texas Somewhat interested	Cultivating HIV Advocacy and Expertise in Texas Neutral	Cultivating HIV Advocacy and Expertise in Texas Not so interested	Cultivating HIV Advocacy and Expertise in Texas No interest
Changing the Message to Improve Results	Changing the Message to Improve Results Very Interested	Changing the Message to Improve Results Somewhat interested	Changing the Message to Improve Results Neutral	Changing the Message to Improve Results Not so interested	Changing the Message to Improve Results No interest
Success in Leadership at All Organizational Levels	Success in Leadership at All Organizational Levels Very Interested	Success in Leadership at All Organizational Levels Somewhat interested	Success in Leadership at All Organizational Levels Neutral	Success in Leadership at All Organizational Levels Not so interested	Success in Leadership at All Organizational Levels No interest
Coordination with Unlikely Allies	Coordination with Unlikely Allies Very Interested	Coordination with Unlikely Allies Somewhat interested	Coordination with Unlikely Allies Neutral	Coordination with Unlikely Allies Not so interested	Coordination with Unlikely Allies No interest
Perspectives on Leadership	Perspectives on Leadership Very Interested	Perspectives on Leadership Somewhat interested	Perspectives on Leadership Neutral	Perspectives on Leadership Not so interested	Perspectives on Leadership No interest
When State Monies Dry Up, What Do You Do?	When State Monies Dry Up, What Do You Do? Very Interested	When State Monies Dry Up, What Do You Do? Somewhat interested	When State Monies Dry Up, What Do You Do? Neutral	When State Monies Dry Up, What Do You Do? Not so interested	When State Monies Dry Up, What Do You Do? No interest
Institutional Leadership (CBO, ASO, Government Agencies)	Institutional Leadership (CBO, ASO, Government Agencies) Very Interested	Institutional Leadership (CBO, ASO, Government Agencies) Somewhat interested	Institutional Leadership (CBO, ASO, Government Agencies) Neutral	Institutional Leadership (CBO, ASO, Government Agencies) Not so interested	Institutional Leadership (CBO, ASO, Government Agencies) No interest
Building Sustainability	Building Sustainability Very Interested	Building Sustainability Somewhat interested	Building Sustainability Neutral	Building Sustainability Not so interested	Building Sustainability No interest

Please list any other suggested topics for this track:

Question Title

* 10. Are there specific speakers/presenters you'd conferece planner to invite? If so please list the speaker, affiliation, and topic below.

Question Title

* 11. Which type of sessions do you typically find most valuable at conferences?

	Most valuable	Somewhat valuable	Neutral	Not very valuable	Not valuable
Breakout sessions	Breakout sessions Most valuable	Breakout sessions Somewhat valuable	Breakout sessions Neutral	Breakout sessions Not very valuable	Breakout sessions Not valuable
Exhibits	Exhibits Most valuable	Exhibits Somewhat valuable	Exhibits Neutral	Exhibits Not very valuable	Exhibits Not valuable
Discussion /Caucus Groups	Discussion /Caucus Groups Most valuable	Discussion /Caucus Groups Somewhat valuable	Discussion /Caucus Groups Neutral	Discussion /Caucus Groups Not very valuable	Discussion /Caucus Groups Not valuable
Panel Presentations	Panel Presentations Most valuable	Panel Presentations Somewhat valuable	Panel Presentations Neutral	Panel Presentations Not very valuable	Panel Presentations Not valuable
Plenary Sessions	Plenary Sessions Most valuable	Plenary Sessions Somewhat valuable	Plenary Sessions Neutral	Plenary Sessions Not very valuable	Plenary Sessions Not valuable
Poster Presentations	Poster Presentations Most valuable	Poster Presentations Somewhat valuable	Poster Presentations Neutral	Poster Presentations Not very valuable	Poster Presentations Not valuable
Networking	Networking Most valuable	Networking Somewhat valuable	Networking Neutral	Networking Not very valuable	Networking Not valuable
Workshops	Workshops Most valuable	Workshops Somewhat valuable	Workshops Neutral	Workshops Not very valuable	Workshops Not valuable

Other session types (please specify):

Question Title

* 12. What is your overall level of expertise in HIV/STD

Novice: I am still getting my feet wet.

Competent: I have limited experience but hope to learn more.

Proficient: I have considerable experience but would not consider myself an expert.

Expert: I consider myself well-versed in the field of HIV/STD.

DEMOGRAPHICS

Question Title

* 13. Are you employed by a DSHS-funded contractor?

Yes

No

Don't Know

Other (please specify):

Question Title

* 14. What is your job role?

Administrator or Supervisor

Case Manager

Clinician (Licensed)

Data Manager

Disease Intervention Specialist

Epidemiologist

Health Communication/Marketing

Health Educator/Outreach Worker

Prevention Counselor

Trainer

Student

Volunteer

Other (please specify):

Question Title

* 15. What are your licensures?

AP, ACP, LMSW, LSW, SWA

CHES, CHE

LCDC, CADAC

LVN

LPC,LMFT

RN

MD, DO

NP

PA

RPh

Other (please specify)

Question Title

* 16. Please describe your organization.

Community Based Organization (non-profit)

Private Clinic or Practice

Local Health Department or Public Clinic

Hospital

DSHS Regional Office

DSHS Central Office (Austin)

Other Texas State Agency

Educational Institution

Federal Agency

Other (please specify)